Weighing the risks and benefits of neoadjuvant therapy in resectable pancreatic cancer: Neoadjuvant therapy should not be used as part of standard clinical practice Journal Article


Authors: Elarre, P. S.; Yu, K. H.
Article Title: Weighing the risks and benefits of neoadjuvant therapy in resectable pancreatic cancer: Neoadjuvant therapy should not be used as part of standard clinical practice
Journal Title: Oncology (Norwalk)
Volume: 32
Issue: 1
ISSN: 0890-9091
Publisher: C M P Medica LLC * The Oncology Group  
Date Published: 2018-01-01
Start Page: 39, 42
End Page: 44
Language: English
PROVIDER: scopus
PUBMED: 29447421
DOI/URL:
Notes: Article -- Export Date: 1 July 2021 -- Source: Scopus
Citation Impact
MSK Authors
  1. Kenneth Ho-Ming Yu
    163 Yu
Related MSK Work